MedPath
HSA Approval

METHYCOBAL INJECTION 500 mcg/ml

SIN06349P

METHYCOBAL INJECTION 500 mcg/ml

METHYCOBAL INJECTION 500 mcg/ml

July 3, 1991

EISAI (SINGAPORE) PTE. LTD.

EISAI (SINGAPORE) PTE. LTD.

Regulatory Information

EISAI (SINGAPORE) PTE. LTD.

EISAI (SINGAPORE) PTE. LTD.

Therapeutic

General Sale List

Formulation Information

INJECTION

**【DOSAGE AND ADMINISTRATION】** - **Peripheral neuropathies** The usual dosage for adults is 1 ampoule (500 mcg of mecobalamin) per day, administered intramuscularly or intravenously 3 times a week. The dosage may be adjusted depending on the patient's age and symptoms. - **Megaloblastic anemia** The usual dosage for adults is 1 ampoule (500 mcg of mecobalamin) per day, administered intramuscularly or intravenously 3 times a week. After about 2 months of medication, the dose should be reduced to a single administration of 1 ampoule at 1 to 3 months intervals for maintenance therapy.

INTRAVENOUS

Medical Information

**【INDICATIONS】** Peripheral neuropathies Megaloblastic anemia caused by vitamin B12 deficiency < **Precautions** > METHYCOBAL should not be used aimlessly for more than one month unless it is effective.

**2\. Contraindication** Hypersensitivity to any form of vitamin B12 or D-mannitol.

B03BA05

mecobalamin

Manufacturer Information

EISAI (SINGAPORE) PTE. LTD.

Nipro Pharma Corporation Ise Plant

Active Ingredients

MECOBALAMIN

500 mcg/ml

Mecobalamin

Documents

Package Inserts

Methycobal Injection PI.pdf

Approved: September 20, 2017

Download
© Copyright 2025. All Rights Reserved by MedPath